Lifestyle factors and comorbidities in gout patients compared to the general population in Western Sweden: results from a questionnaire study

Objective This study aimed to identify lifestyle factors associated with gout in patients with prevalent gout compared to the general population. Method Adult patients with gout identified in primary and secondary care in Western Sweden between 2015 and 2017 were sent a questionnaire asking about demographics, lifestyle, and comorbidities. Five age- and gender-matched controls were identified in a random sample of 52 348 individuals aged 16–84 years who participated in the National Public Health survey in Sweden, year 2015. Logistic regression models were used to compare cases and controls with regard to lifestyle factors and comorbidities. Results Of the 1589 invited gout patients, 868 (55%) responded. After matching for age and gender, 728 were included in the analysis (82.4% male; mean ± sd age 69.3 ± 10.5 years for men and 71.8 ± 9.9 years for women with gout). Male and female gout patients were significantly more likely to be overweight or obese (men 79% vs 66%; women 78.5% vs 65.3%), to have binge-drinking behaviour (men 29.9% vs 11%; women 13.7% vs 2.9%), and to be ex-smokers, compared to controls. Moreover, male gout patients reported lower levels of physical activity, while diabetes and hypertension were more common in both genders with gout than in controls. Conclusion In this questionnaire study, gout patients reported significantly more obesity and binge-drinking behaviour and less physical activity than controls. This suggests that there are great unmet needs for the management of lifestyle factors, particularly regarding overweight/obesity and binge drinking, in patients with gout.

[1]  L. Jacobsson,et al.  The Validity of Gout Diagnosis in Primary Care: Results from a Patient Survey , 2019, The Journal of Rheumatology.

[2]  P. Nilsson,et al.  The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden , 2018, Arthritis Research & Therapy.

[3]  L. Jacobsson,et al.  Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy , 2018, Arthritis Research & Therapy.

[4]  T. Merriman,et al.  An association of smoking with serum urate and gout: A health paradox. , 2017, Seminars in arthritis and rheumatism.

[5]  A. Astrup,et al.  Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies , 2017, Annals of the rheumatic diseases.

[6]  M. Petzold,et al.  Factors associated with initiation and persistence of urate-lowering therapy , 2017, Arthritis Research & Therapy.

[7]  P. Restani,et al.  Drinking pattern of wine and effects on human health: why should we drink moderately and with meals? , 2016, Food & function.

[8]  L. Jacobsson,et al.  Validity of gout diagnosis in Swedish primary and secondary care - a validation study , 2015, BMC Musculoskeletal Disorders.

[9]  F. Becce,et al.  2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.

[10]  D. Hunter,et al.  Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. , 2014, The American journal of medicine.

[11]  Hyon K. Choi,et al.  Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. , 2012, The American journal of medicine.

[12]  R. Glynn,et al.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. , 1987, The American journal of medicine.